A case of hypersensitivity to soluble and isophane insulins but not to insulin glargine

Insulin is an important agent for the treatment of diabetes mellitus (DM). Allergic reactions to insulin therapy, although rare, have been evident since animal insulin became available for the treatment of DM in 1922. Hypersensitivity to insulin has considerably been reduced with the introduction of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of pharmacology 2015-03, Vol.47 (2), p.227-229
Hauptverfasser: Belhekar, Mahesh N, Pai, Sarayu, Tayade, Parimal, Dalwadi, Pradip, Munshi, Renuka, Varthakavi, Prema
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 229
container_issue 2
container_start_page 227
container_title Indian journal of pharmacology
container_volume 47
creator Belhekar, Mahesh N
Pai, Sarayu
Tayade, Parimal
Dalwadi, Pradip
Munshi, Renuka
Varthakavi, Prema
description Insulin is an important agent for the treatment of diabetes mellitus (DM). Allergic reactions to insulin therapy, although rare, have been evident since animal insulin became available for the treatment of DM in 1922. Hypersensitivity to insulin has considerably been reduced with the introduction of human insulin produced by recombinant deoxyribonucleic acid technology. Here, we present a case of Type 2 DM who demonstrated immediate (Type 1) hypersensitivity reaction on the sites of subcutaneous injection of soluble and isophane insulin but insulin glargine was tolerated well and provided good glycemic control.
doi_str_mv 10.4103/0253-7613.153438
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4386139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A406918673</galeid><sourcerecordid>A406918673</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-50c8a49f99249a25afb349c424d57a4cae93a44fc00ebe2573151dd825433ed93</originalsourceid><addsrcrecordid>eNptUk2LFDEUDKK44-rdkwS8eOkxn92dizAsugoLXhSPIZ1-3ZMlk4xJ98L8e9PM7OjKEEjIe1WVvKIQekvJWlDCPxImedXUlK-p5IK3z9CKKtVWvJH0OVqd21foVc73pNyFql-iKybbpuWKrNCvDbYmA44D3h72kDKE7Cb34KYDniLO0c-dB2xCj12O-60JgF3Isy8b7uYJhzgtwFMNj96k0QV4jV4Mxmd4czqv0c8vn3_cfK3uvt9-u9ncVVYyNVWS2NYINSjFhDJMmqHjQlnBRC8bI6wBxY0QgyUEOmCy4VTSvm_LIJxDr_g1-nTU3c_dDnoLYUrG631yO5MOOhqnn3aC2-oxPujiVjFmEfhwEkjx9wx50juXLXhfJo1z1rRuBCM1obxA3_8HvY9zCmW8BVXLmnBG_6JG40G7MMTyrl1E9UaQWtG2bhat6gJqhADlkzHA4Er5CX59AV9WDztnLxLIkWBTzDnBcPaEEr2ERy_p0Es69DE8hfLuXy_PhMe08D9pl73X</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1676560321</pqid></control><display><type>article</type><title>A case of hypersensitivity to soluble and isophane insulins but not to insulin glargine</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Belhekar, Mahesh N ; Pai, Sarayu ; Tayade, Parimal ; Dalwadi, Pradip ; Munshi, Renuka ; Varthakavi, Prema</creator><creatorcontrib>Belhekar, Mahesh N ; Pai, Sarayu ; Tayade, Parimal ; Dalwadi, Pradip ; Munshi, Renuka ; Varthakavi, Prema</creatorcontrib><description>Insulin is an important agent for the treatment of diabetes mellitus (DM). Allergic reactions to insulin therapy, although rare, have been evident since animal insulin became available for the treatment of DM in 1922. Hypersensitivity to insulin has considerably been reduced with the introduction of human insulin produced by recombinant deoxyribonucleic acid technology. Here, we present a case of Type 2 DM who demonstrated immediate (Type 1) hypersensitivity reaction on the sites of subcutaneous injection of soluble and isophane insulin but insulin glargine was tolerated well and provided good glycemic control.</description><identifier>ISSN: 0253-7613</identifier><identifier>EISSN: 1998-3751</identifier><identifier>DOI: 10.4103/0253-7613.153438</identifier><identifier>PMID: 25878390</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Adult ; Allergies ; Blood Glucose - analysis ; Case studies ; Complications and side effects ; Diabetes ; Dosage and administration ; Drug hypersensitivity ; Drug Watch ; Female ; Humans ; Hypersensitivity, Immediate - blood ; Hypersensitivity, Immediate - chemically induced ; Hypersensitivity, Immediate - immunology ; Immunoglobulin E - blood ; Insulin ; Insulin Glargine - administration &amp; dosage ; Insulin Glargine - adverse effects ; Insulin Glargine - therapeutic use ; Insulin, Isophane - administration &amp; dosage ; Insulin, Isophane - adverse effects ; Insulin, Isophane - therapeutic use ; Insulin, Regular, Pork - administration &amp; dosage ; Insulin, Regular, Pork - adverse effects ; Insulin, Regular, Pork - therapeutic use ; Treatment Outcome</subject><ispartof>Indian journal of pharmacology, 2015-03, Vol.47 (2), p.227-229</ispartof><rights>COPYRIGHT 2015 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Apr 2015</rights><rights>Copyright: © Indian Journal of Pharmacology 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-50c8a49f99249a25afb349c424d57a4cae93a44fc00ebe2573151dd825433ed93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386139/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386139/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25878390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Belhekar, Mahesh N</creatorcontrib><creatorcontrib>Pai, Sarayu</creatorcontrib><creatorcontrib>Tayade, Parimal</creatorcontrib><creatorcontrib>Dalwadi, Pradip</creatorcontrib><creatorcontrib>Munshi, Renuka</creatorcontrib><creatorcontrib>Varthakavi, Prema</creatorcontrib><title>A case of hypersensitivity to soluble and isophane insulins but not to insulin glargine</title><title>Indian journal of pharmacology</title><addtitle>Indian J Pharmacol</addtitle><description>Insulin is an important agent for the treatment of diabetes mellitus (DM). Allergic reactions to insulin therapy, although rare, have been evident since animal insulin became available for the treatment of DM in 1922. Hypersensitivity to insulin has considerably been reduced with the introduction of human insulin produced by recombinant deoxyribonucleic acid technology. Here, we present a case of Type 2 DM who demonstrated immediate (Type 1) hypersensitivity reaction on the sites of subcutaneous injection of soluble and isophane insulin but insulin glargine was tolerated well and provided good glycemic control.</description><subject>Adult</subject><subject>Allergies</subject><subject>Blood Glucose - analysis</subject><subject>Case studies</subject><subject>Complications and side effects</subject><subject>Diabetes</subject><subject>Dosage and administration</subject><subject>Drug hypersensitivity</subject><subject>Drug Watch</subject><subject>Female</subject><subject>Humans</subject><subject>Hypersensitivity, Immediate - blood</subject><subject>Hypersensitivity, Immediate - chemically induced</subject><subject>Hypersensitivity, Immediate - immunology</subject><subject>Immunoglobulin E - blood</subject><subject>Insulin</subject><subject>Insulin Glargine - administration &amp; dosage</subject><subject>Insulin Glargine - adverse effects</subject><subject>Insulin Glargine - therapeutic use</subject><subject>Insulin, Isophane - administration &amp; dosage</subject><subject>Insulin, Isophane - adverse effects</subject><subject>Insulin, Isophane - therapeutic use</subject><subject>Insulin, Regular, Pork - administration &amp; dosage</subject><subject>Insulin, Regular, Pork - adverse effects</subject><subject>Insulin, Regular, Pork - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0253-7613</issn><issn>1998-3751</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptUk2LFDEUDKK44-rdkwS8eOkxn92dizAsugoLXhSPIZ1-3ZMlk4xJ98L8e9PM7OjKEEjIe1WVvKIQekvJWlDCPxImedXUlK-p5IK3z9CKKtVWvJH0OVqd21foVc73pNyFql-iKybbpuWKrNCvDbYmA44D3h72kDKE7Cb34KYDniLO0c-dB2xCj12O-60JgF3Isy8b7uYJhzgtwFMNj96k0QV4jV4Mxmd4czqv0c8vn3_cfK3uvt9-u9ncVVYyNVWS2NYINSjFhDJMmqHjQlnBRC8bI6wBxY0QgyUEOmCy4VTSvm_LIJxDr_g1-nTU3c_dDnoLYUrG631yO5MOOhqnn3aC2-oxPujiVjFmEfhwEkjx9wx50juXLXhfJo1z1rRuBCM1obxA3_8HvY9zCmW8BVXLmnBG_6JG40G7MMTyrl1E9UaQWtG2bhat6gJqhADlkzHA4Er5CX59AV9WDztnLxLIkWBTzDnBcPaEEr2ERy_p0Es69DE8hfLuXy_PhMe08D9pl73X</recordid><startdate>20150301</startdate><enddate>20150301</enddate><creator>Belhekar, Mahesh N</creator><creator>Pai, Sarayu</creator><creator>Tayade, Parimal</creator><creator>Dalwadi, Pradip</creator><creator>Munshi, Renuka</creator><creator>Varthakavi, Prema</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150301</creationdate><title>A case of hypersensitivity to soluble and isophane insulins but not to insulin glargine</title><author>Belhekar, Mahesh N ; Pai, Sarayu ; Tayade, Parimal ; Dalwadi, Pradip ; Munshi, Renuka ; Varthakavi, Prema</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-50c8a49f99249a25afb349c424d57a4cae93a44fc00ebe2573151dd825433ed93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Allergies</topic><topic>Blood Glucose - analysis</topic><topic>Case studies</topic><topic>Complications and side effects</topic><topic>Diabetes</topic><topic>Dosage and administration</topic><topic>Drug hypersensitivity</topic><topic>Drug Watch</topic><topic>Female</topic><topic>Humans</topic><topic>Hypersensitivity, Immediate - blood</topic><topic>Hypersensitivity, Immediate - chemically induced</topic><topic>Hypersensitivity, Immediate - immunology</topic><topic>Immunoglobulin E - blood</topic><topic>Insulin</topic><topic>Insulin Glargine - administration &amp; dosage</topic><topic>Insulin Glargine - adverse effects</topic><topic>Insulin Glargine - therapeutic use</topic><topic>Insulin, Isophane - administration &amp; dosage</topic><topic>Insulin, Isophane - adverse effects</topic><topic>Insulin, Isophane - therapeutic use</topic><topic>Insulin, Regular, Pork - administration &amp; dosage</topic><topic>Insulin, Regular, Pork - adverse effects</topic><topic>Insulin, Regular, Pork - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Belhekar, Mahesh N</creatorcontrib><creatorcontrib>Pai, Sarayu</creatorcontrib><creatorcontrib>Tayade, Parimal</creatorcontrib><creatorcontrib>Dalwadi, Pradip</creatorcontrib><creatorcontrib>Munshi, Renuka</creatorcontrib><creatorcontrib>Varthakavi, Prema</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Belhekar, Mahesh N</au><au>Pai, Sarayu</au><au>Tayade, Parimal</au><au>Dalwadi, Pradip</au><au>Munshi, Renuka</au><au>Varthakavi, Prema</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case of hypersensitivity to soluble and isophane insulins but not to insulin glargine</atitle><jtitle>Indian journal of pharmacology</jtitle><addtitle>Indian J Pharmacol</addtitle><date>2015-03-01</date><risdate>2015</risdate><volume>47</volume><issue>2</issue><spage>227</spage><epage>229</epage><pages>227-229</pages><issn>0253-7613</issn><eissn>1998-3751</eissn><abstract>Insulin is an important agent for the treatment of diabetes mellitus (DM). Allergic reactions to insulin therapy, although rare, have been evident since animal insulin became available for the treatment of DM in 1922. Hypersensitivity to insulin has considerably been reduced with the introduction of human insulin produced by recombinant deoxyribonucleic acid technology. Here, we present a case of Type 2 DM who demonstrated immediate (Type 1) hypersensitivity reaction on the sites of subcutaneous injection of soluble and isophane insulin but insulin glargine was tolerated well and provided good glycemic control.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>25878390</pmid><doi>10.4103/0253-7613.153438</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0253-7613
ispartof Indian journal of pharmacology, 2015-03, Vol.47 (2), p.227-229
issn 0253-7613
1998-3751
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4386139
source MEDLINE; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Adult
Allergies
Blood Glucose - analysis
Case studies
Complications and side effects
Diabetes
Dosage and administration
Drug hypersensitivity
Drug Watch
Female
Humans
Hypersensitivity, Immediate - blood
Hypersensitivity, Immediate - chemically induced
Hypersensitivity, Immediate - immunology
Immunoglobulin E - blood
Insulin
Insulin Glargine - administration & dosage
Insulin Glargine - adverse effects
Insulin Glargine - therapeutic use
Insulin, Isophane - administration & dosage
Insulin, Isophane - adverse effects
Insulin, Isophane - therapeutic use
Insulin, Regular, Pork - administration & dosage
Insulin, Regular, Pork - adverse effects
Insulin, Regular, Pork - therapeutic use
Treatment Outcome
title A case of hypersensitivity to soluble and isophane insulins but not to insulin glargine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A34%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20of%20hypersensitivity%20to%20soluble%20and%20isophane%20insulins%20but%20not%20to%20insulin%20glargine&rft.jtitle=Indian%20journal%20of%20pharmacology&rft.au=Belhekar,%20Mahesh%20N&rft.date=2015-03-01&rft.volume=47&rft.issue=2&rft.spage=227&rft.epage=229&rft.pages=227-229&rft.issn=0253-7613&rft.eissn=1998-3751&rft_id=info:doi/10.4103/0253-7613.153438&rft_dat=%3Cgale_pubme%3EA406918673%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1676560321&rft_id=info:pmid/25878390&rft_galeid=A406918673&rfr_iscdi=true